187 related articles for article (PubMed ID: 37872047)
21. Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.
Lin Y; Wu ZR; Shi YP; Ding M; Tang XY; He Y; Zhai B; Li P
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1298-e1305. PubMed ID: 37220176
[TBL] [Abstract][Full Text] [Related]
22. Active surveillance of low-risk papillary thyroid microcarcinoma.
Sugitani I
Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101630. PubMed ID: 35256266
[TBL] [Abstract][Full Text] [Related]
23. Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma.
Miyauchi A; Ito Y
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):215-226. PubMed ID: 30717903
[TBL] [Abstract][Full Text] [Related]
24. Five-year Outcome Between Radiofrequency Ablation vs Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
Yan L; Yang Z; Li Y; Li X; Xiao J; Jing H; Luo Y
J Clin Endocrinol Metab; 2023 Nov; 108(12):3230-3238. PubMed ID: 37318878
[TBL] [Abstract][Full Text] [Related]
25. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
26. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
[No Abstract] [Full Text] [Related]
27. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients.
Yan L; Lan Y; Xiao J; Lin L; Jiang B; Luo Y
Eur Radiol; 2021 Feb; 31(2):685-694. PubMed ID: 32813103
[TBL] [Abstract][Full Text] [Related]
28. Clinical Effects of Microwave Ablation in the Treatment of Low-Risk Papillary Thyroid Microcarcinomas and Related Histopathological Changes.
Lu C; Li X; Chu X; Li R; Li J; Wang J; Wang Y; Xu Y; Chen G; Xu S; Liu C
Front Endocrinol (Lausanne); 2021; 12():751213. PubMed ID: 34603216
[TBL] [Abstract][Full Text] [Related]
29. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
30. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the efficacy and safety of ultrasound-guided radiofrequency ablation and microwave ablation for the treatment of unifocal papillary thyroid microcarcinoma: a retrospective study.
Li N; Dong Y; Ding Y; Cui G; Hua Q; Xia S; Zhou J
Int J Hyperthermia; 2024; 41(1):2287964. PubMed ID: 38223997
[TBL] [Abstract][Full Text] [Related]
32. Long-term efficacy of microwave ablation for multifocal papillary thyroid microcarcinoma: a 5-year follow-up study.
Dong P; Teng DK; Sui GQ; Lin YQ; Luo Q; Wang QM; Li HQ; Wang H
Eur Radiol; 2024 Jan; 34(1):715-723. PubMed ID: 37581653
[TBL] [Abstract][Full Text] [Related]
33. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
34. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Surgery; 2024 Apr; 175(4):1089-1094. PubMed ID: 38142143
[TBL] [Abstract][Full Text] [Related]
35. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
36. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma in patients aged 55 years or older: a retrospective study.
He H; Song Q; Lan Y; Yan L; Xiao J; Zhang Y; Luo Y
Int J Hyperthermia; 2021; 38(1):604-610. PubMed ID: 33853489
[TBL] [Abstract][Full Text] [Related]
39. [Discussion on how to optimize active surveillance for low-risk papillary thyroid microcarcinoma in China].
Xue S; Wang PS; Lu QY; Chen G
Zhonghua Wai Ke Za Zhi; 2023 Jun; 61(6):462-466. PubMed ID: 37088477
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation for papillary thyroid microcarcinoma with a trachea-adjacent versus trachea-distant location.
Jing H; Yan L; Xiao J; Li X; Jiang B; Yang Z; Li Y; Sun B; Zhang M; Luo Y
Int J Hyperthermia; 2024; 41(1):2270671. PubMed ID: 38214143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
